{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:30:28Z","timestamp":1787506228301,"version":"build-2736575974"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T00:00:00Z","timestamp":1650585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,30]]},"abstract":"Abstract<\/jats:title>\n \n STUDY QUESTION<\/jats:title>\n Do polymorphisms in the anti-M\u00fcllerian hormone (AMH) promoter have an effect on AMH levels in patients with polycystic ovary syndrome (PCOS)?<\/jats:p>\n <\/jats:sec>\n \n SUMMARY ANSWER<\/jats:title>\n We have identified a novel AMH promoter polymorphism rs10406324 that is associated with lower serum AMH levels and is suggested to play a role in the mechanism of regulation of AMH gene expression in women.<\/jats:p>\n <\/jats:sec>\n \n WHAT IS KNOWN ALREADY<\/jats:title>\n Follicle number is positively correlated with serum AMH levels, reflected by elevated AMH levels in women with PCOS. In addition, it is suggested that AMH production per follicle is higher in women with PCOS than in normo-ovulatory women, implying an altered regulation of AMH in PCOS.<\/jats:p>\n <\/jats:sec>\n \n STUDY DESIGN, SIZE, DURATION<\/jats:title>\n A discovery cohort of 655 PCOS women of Northern European ancestry and both an internal and external validation PCOS cohort (n\u2009=\u2009458 and n\u2009=\u2009321, respectively) were included in this study. Summary-level data of an AMH genome-wide association study meta-analysis including 7049 normo-ovulatory women was included as a control cohort. A genetic approach was taken through association analysis and in silico analysis of the associated variants in the AMH promoter. In vitro analysis was performed to investigate the functional mechanisms.<\/jats:p>\n <\/jats:sec>\n \n PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n All common two-allelic single-nucleotide polymorphisms (SNPs) in the region Chr19:2\u200a245\u200a353\u20132\u200a250\u200a827 bp (Build 37) were selected for the analysis. Linear regression analyses were performed to determine the association between SNPs in the AMH promoter region and serum AMH levels. For the in silico analysis, the webtools \u2018HaploReg\u2019 v4.1 for ENCODE prediction weight matrices and \u2018atSNP\u2019 were used. In vitro analysis was performed using KK1 cells, a mouse granulosa cell line and COV434 cells, a human granulosa tumor cell line. Cells were transfected with the reference or the variant human AMH promoter reporter construct together with several transcription factors (TFs). Dual-Glo\u00ae Luciferase Assay was performed to measure the luciferase activity.<\/jats:p>\n <\/jats:sec>\n \n MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n Polymorphism rs10406324 was significantly associated with serum AMH levels in all three PCOS cohorts. Carriers of the minor allele G had significantly lower log-transformed serum AMH levels compared to non-carriers (P\u2009=\u20098.58\u2009\u00d7\u200910\u22128, P\u2009=\u20091.35\u2009\u00d7\u200910\u22123 and P\u2009=\u20091.24\u2009\u00d7\u200910\u22123, respectively). This result was validated in a subsequent meta-analysis (P\u2009=\u20093.24\u2009\u00d7\u200910\u221212). Interestingly, rs10406324 was not associated with follicle count, nor with other clinical traits. Also, in normo-ovulatory women, the minor allele of this variant was associated with lower serum AMH levels (P\u2009=\u20091.04\u2009\u00d7\u200910\u22125). These findings suggest that polymorphism rs10406324 plays a role in the regulation of AMH expression, irrespective of clinical background. In silico analysis suggested a decreased binding affinity of the TFs steroidogenenic factor 1, estrogen-related receptor alpha and glucocorticoid receptor to the minor allele G variant, however in vitro analysis did not show a difference in promoter activity between the A and G allele.<\/jats:p>\n <\/jats:sec>\n \n LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n Functional analyses were performed in a mouse and a human granulosa cell line using an AMH promoter reporter construct. This may have limited assessment of the impact of the polymorphism on higher order chromatin structures. Human granulosa cells generated from induced pluripotent stem cells, combined with gene editing, may provide a method to elucidate the exact mechanism behind the decrease in serum AMH levels in carriers of the \u2212210 G allele. We acknowledge that the lack of follicle number in the external validation and the control cohort is a limitation of the paper. Although we observed that the association between rs10406324 and AMH levels was independent of follicle number in our discovery and internal validation PCOS cohorts, we cannot fully rule out that the observed effects on serum AMH levels are, in part, caused by differences in follicle number.<\/jats:p>\n <\/jats:sec>\n \n WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n These results suggest that variations in serum AMH levels are not only caused by differences in follicle number but also by genetic factors. Therefore, the genetic context should be taken into consideration when assessing serum AMH levels in women. This may have clinical consequences when serum AMH levels are used as a marker for the polycystic ovarian morphology phenotype.<\/jats:p>\n <\/jats:sec>\n \n STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n No external funding was used. J.S.E.L. has received consultancy fees from the following companies: Ferring, Roche Diagnostics and Ansh Labs and has received travel reimbursement from Ferring. J.A.V. has received royalties from AMH assays, paid to the institute\/lab with no personal financial gain. The other authors declare no competing interests.<\/jats:p>\n <\/jats:sec>\n \n TRIAL REGISTRATION NUMBER<\/jats:title>\n N\/A.<\/jats:p>\n <\/jats:sec>","DOI":"10.1093\/humrep\/deac082","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T07:15:09Z","timestamp":1649920509000},"page":"1544-1556","source":"Crossref","is-referenced-by-count":25,"title":["Association between an AMH promoter polymorphism and serum AMH levels in PCOS patients"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3012-4675","authenticated-orcid":false,"given":"Loes M E","family":"Moolhuijsen","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Erasmus MC, University Medical Center , Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne V","family":"Louwers","sequence":"additional","affiliation":[{"name":"Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynaecology, Erasmus MC, University Medical Center , Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"McLuskey","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Erasmus MC, University Medical Center , Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Broer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Erasmus MC, University Medical Center , Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre G","family":"Uitterlinden","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Erasmus MC, University Medical Center , Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2061-0530","authenticated-orcid":false,"given":"Ren\u00e9e M G","family":"Verdiesen","sequence":"additional","affiliation":[{"name":"Division of Molecular Pathology, The Netherlands Cancer Institute\u2014Antoni van Leeuwenhoek Hospital , Amsterdam, the Netherlands"},{"name":"Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University , Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan K","family":"Sisk","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine , Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Dunaif","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai , New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joop S E","family":"Laven","sequence":"additional","affiliation":[{"name":"Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynaecology, Erasmus MC, University Medical Center , Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7182-3571","authenticated-orcid":false,"given":"Jenny A","family":"Visser","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Erasmus MC, University Medical Center , Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,4,22]]},"reference":[{"key":"2022070318263463800_deac082-B1","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/humrep\/dey098","article-title":"Discordance between serum anti-Mullerian hormone concentrations and antral follicle counts: not only technical issues","volume":"33","author":"Alebic","year":"2018","journal-title":"Hum Reprod"},{"key":"2022070318263463800_deac082-B2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.fertnstert.2014.10.033","article-title":"Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimullerian hormone than its counterpart in a normal ovary: an observational cross-sectional study","volume":"103","author":"Bhide","year":"2015","journal-title":"Fertil Steril"},{"key":"2022070318263463800_deac082-B3","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1210\/mend.11.7.9948","article-title":"The ERR-1 orphan receptor is a transcriptional activator expressed during bone development","volume":"11","author":"Bonnelye","year":"1997","journal-title":"Mol Endocrinol"},{"key":"2022070318263463800_deac082-B4","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"key":"2022070318263463800_deac082-B5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cca.2015.08.019","article-title":"Testosterone, free testosterone, and free androgen index in women: reference intervals, biological variation, and diagnostic value in polycystic ovary syndrome","volume":"450","author":"Bui","year":"2015","journal-title":"Clin Chim Acta"},{"key":"2022070318263463800_deac082-B6","doi-asserted-by":"crossref","first-page":"7476","DOI":"10.1128\/MCB.00103-08","article-title":"Decreased recognition of SUMO-sensitive target genes following modification of SF-1 (NR5A1)","volume":"28","author":"Campbell","year":"2008","journal-title":"Mol Cell Biol"},{"key":"2022070318263463800_deac082-B7","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0092-8674(86)90783-X","article-title":"Isolation of the bovine and human genes for Mullerian inhibiting substance and expression of the human gene in animal cells","volume":"45","author":"Cate","year":"1986","journal-title":"Cell"},{"key":"2022070318263463800_deac082-B8","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1210\/jc.2008-1231","article-title":"Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome","volume":"93","author":"Catteau-Jonard","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2022070318263463800_deac082-B9","doi-asserted-by":"crossref","first-page":"e0146739","DOI":"10.1371\/journal.pone.0146739","article-title":"Does AMH reflect follicle number similarly in women with and without PCOS?","volume":"11","author":"Christiansen","year":"2016","journal-title":"PLoS One"},{"key":"2022070318263463800_deac082-B10","doi-asserted-by":"crossref","first-page":"e1003132","DOI":"10.1371\/journal.pmed.1003132","article-title":"Distinct subtypes of polycystic ovary syndrome with novel genetic associations: an unsupervised, phenotypic clustering analysis","volume":"17","author":"Dapas","year":"2020","journal-title":"PLoS Med"},{"key":"2022070318263463800_deac082-B11","doi-asserted-by":"crossref","first-page":"e1007813","DOI":"10.1371\/journal.pgen.1007813","article-title":"Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria","volume":"14","author":"Day","year":"2018","journal-title":"PLoS Genet"},{"key":"2022070318263463800_deac082-B12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bpobgyn.2016.03.009","article-title":"Diagnostic criteria for PCOS: Is there a need for a rethink?","volume":"37","author":"Dewailly","year":"2016","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2022070318263463800_deac082-B13","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3389\/fendo.2020.00641","article-title":"Role of anti-Mullerian hormone in the pathogenesis of polycystic ovary syndrome","volume":"11","author":"Dewailly","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2022070318263463800_deac082-B14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/humupd\/dmt061","article-title":"Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"2022070318263463800_deac082-B15","first-page":"2467","article-title":"The regulation and signalling of anti-Mullerian hormone in human granulosa cells: relevance to polycystic ovary syndrome","volume":"34","author":"Dilaver","year":"2019","journal-title":"Hum Reprod"},{"key":"2022070318263463800_deac082-B16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rbmo.2016.04.007","article-title":"The role of AMH in the pathophysiology of polycystic ovarian syndrome","volume":"33","author":"Garg","year":"2016","journal-title":"Reprod Biomed Online"},{"key":"2022070318263463800_deac082-B17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"2022070318263463800_deac082-B18","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1210\/jc.2018-02178","article-title":"Functional genetic variation in the anti-mullerian hormone pathway in women with polycystic ovary syndrome","volume":"104","author":"Gorsic","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2022070318263463800_deac082-B19","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1210\/jc.2017-00612","article-title":"Pathogenic anti-mullerian hormone variants in polycystic ovary syndrome","volume":"102","author":"Gorsic","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2022070318263463800_deac082-B20","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1002\/j.1460-2075.1994.tb06726.x","article-title":"A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1","volume":"13","author":"Heck","year":"1994","journal-title":"EMBO J"},{"key":"2022070318263463800_deac082-B21","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1093\/humrep\/deaa199","article-title":"Loss of anti-Mullerian hormone (AMH) immunoactivity due to a homozygous AMH gene variant rs10417628 in a woman with classical polycystic ovary syndrome (PCOS)","volume":"35","author":"Hoyos","year":"2020","journal-title":"Hum Reprod"},{"key":"2022070318263463800_deac082-B22","doi-asserted-by":"crossref","first-page":"50991","DOI":"10.1074\/jbc.M210262200","article-title":"Identification of a specific molecular repressor of the peroxisome proliferator-activated receptor gamma Coactivator-1 alpha (PGC-1alpha)","volume":"277","author":"Ichida","year":"2002","journal-title":"J Biol Chem"},{"key":"2022070318263463800_deac082-B23","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10654-020-00640-5","article-title":"Objectives, design and main findings until 2020 from the Rotterdam Study","volume":"35","author":"Ikram","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"2022070318263463800_deac082-B24","doi-asserted-by":"crossref","first-page":"e0159112","DOI":"10.1371\/journal.pone.0159112","article-title":"FOXL2 is an essential activator of SF-1-induced transcriptional regulation of anti-mullerian hormone in human granulosa cells","volume":"11","author":"Jin","year":"2016","journal-title":"PLoS One"},{"key":"2022070318263463800_deac082-B25","first-page":"616","article-title":"Gonadal tumorigenesis in transgenic mice bearing the mouse inhibin alpha-subunit promoter\/simian virus T-antigen fusion gene: characterization of ovarian tumors and establishment of gonadotropin-responsive granulosa cell lines","volume":"9","author":"Kananen","year":"1995","journal-title":"Mol Endocrinol"},{"key":"2022070318263463800_deac082-B26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3109\/09513590.2013.798279","article-title":"Anti-Mullerian hormone (AMH) downregulation in late antral stages is impaired in PCOS patients. A study in normo-ovulatory and PCOS patients undergoing in vitro maturation (IVM) treatments","volume":"29","author":"Kedem","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"2022070318263463800_deac082-B27","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1210\/jc.2007-2205","article-title":"A functional anti-mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients","volume":"93","author":"Kevenaar","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2022070318263463800_deac082-B28","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1093\/nar\/gkt1249","article-title":"Systematic discovery and characterization of regulatory motifs in ENCODE TF binding experiments","volume":"42","author":"Kheradpour","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2022070318263463800_deac082-B29","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.molcel.2019.08.010","article-title":"Mechanisms of interplay between transcription factors and the 3D genome","volume":"76","author":"Kim","year":"2019","journal-title":"Mol Cell"},{"key":"2022070318263463800_deac082-B30","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1210\/jc.2019-01094","article-title":"Quantitative differences in TGF-beta family members measured in small antral follicle fluids from women with or without PCO","volume":"104","author":"Kristensen","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2022070318263463800_deac082-B31","first-page":"47","article-title":"Anti-mullerian hormone (AMH) as a good predictor of time of menopause","volume":"16","author":"Kruszynska","year":"2017","journal-title":"Prz Menopauzalny"},{"key":"2022070318263463800_deac082-B32","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","article-title":"Anti-Mullerian hormone serum concentrations in and anovulatory women of reproductive age","volume":"89","author":"Laven","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2022070318263463800_deac082-B33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/sj.hdy.6800717","article-title":"Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix","volume":"95","author":"Li","year":"2005","journal-title":"Heredity (Edinb)"},{"key":"2022070318263463800_deac082-B34","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/humrep\/dex226","article-title":"Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Mullerian hormone using cluster analysis","volume":"32","author":"Lie Fong","year":"2017","journal-title":"Hum Reprod"},{"key":"2022070318263463800_deac082-B35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"2022070318263463800_deac082-B36","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s10815-015-0538-7","article-title":"Obesity adversely affects serum anti-mullerian hormone (AMH) levels in Caucasian women","volume":"32","author":"Moy","year":"2015","journal-title":"J Assist Reprod Genet"},{"key":"2022070318263463800_deac082-B37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0038-1668085","article-title":"A summary on polycystic ovary syndrome: diagnostic criteria, prevalence, clinical manifestations, and management according to the Latest International Guidelines","volume":"36","author":"Neven","year":"2018","journal-title":"Semin Reprod Med"},{"key":"2022070318263463800_deac082-B38","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1210\/jc.2009-2106","article-title":"Serum anti-mullerian hormone concentrations are elevated in oligomenorrheic girls without evidence of hyperandrogenism","volume":"95","author":"Park","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2022070318263463800_deac082-B39","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.fertnstert.2014.05.031","article-title":"Positive cross talk between FOXL2 and antimullerian hormone regulates ovarian reserve","volume":"102","author":"Park","year":"2014","journal-title":"Fertil Steril"},{"key":"2022070318263463800_deac082-B40","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1210\/jc.2017-00308","article-title":"Dysregulation of the anti-mullerian hormone system by steroids in women with polycystic ovary syndrome","volume":"102","author":"Pierre","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2022070318263463800_deac082-B41","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1210\/jc.2003-030727","article-title":"Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest","volume":"88","author":"Pigny","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2022070318263463800_deac082-B42","doi-asserted-by":"crossref","first-page":"D886","DOI":"10.1093\/nar\/gky1016","article-title":"CADD: predicting the deleteriousness of variants throughout the human genome","volume":"47","author":"Rentzsch","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2022070318263463800_deac082-B43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mce.2003.09.007","article-title":"AMH\/MIS: what we know already about the gene, the protein and its regulation","volume":"211","author":"Rey","year":"2003","journal-title":"Mol Cell Endocrinol"},{"key":"2022070318263463800_deac082-B44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"2022070318263463800_deac082-B45","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1093\/hmg\/ddz015","article-title":"Genome-wide association study of anti-Mullerian hormone levels in pre-menopausal women of late reproductive age and relationship with genetic determinants of reproductive lifespan","volume":"28","author":"Ruth","year":"2019","journal-title":"Hum Mol Genet"},{"key":"2022070318263463800_deac082-B46","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1093\/hmg\/ddz147","article-title":"A mutation inactivating the distal SF1 binding site on the human anti-Mullerian hormone promoter causes persistent Mullerian duct syndrome","volume":"28","author":"Schteingart","year":"2019","journal-title":"Hum Mol Genet"},{"key":"2022070318263463800_deac082-B47","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0092-8674(94)90050-7","article-title":"Nuclear receptor steroidogenic factor 1 regulates the mullerian inhibiting substance gene: a link to the sex determination cascade","volume":"77","author":"Shen","year":"1994","journal-title":"Cell"},{"key":"2022070318263463800_deac082-B48","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1093\/bioinformatics\/bty1010","article-title":"atSNP Search: a web resource for statistically evaluating influence of human genetic variation on transcription factor binding","volume":"35","author":"Shin","year":"2019","journal-title":"Bioinformatics"},{"key":"2022070318263463800_deac082-B49","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1126\/science.1262110","article-title":"Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans","volume":"348","year":"2015","journal-title":"Science"},{"key":"2022070318263463800_deac082-B50","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"2022070318263463800_deac082-B51","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0015-0282(97)80068-4","article-title":"Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome","volume":"67","author":"van Santbrink","year":"1997","journal-title":"Fertil Steril"},{"key":"2022070318263463800_deac082-B52","doi-asserted-by":"crossref","DOI":"10.1093\/humrep\/deac028","article-title":"Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Mullerian hormone levels in women","author":"Verdiesen","year":"2022","journal-title":"Hum Reprod"},{"key":"2022070318263463800_deac082-B53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/rep.1.00529","article-title":"Anti-Mullerian hormone: a new marker for ovarian function","volume":"131","author":"Visser","year":"2006","journal-title":"Reproduction"},{"key":"2022070318263463800_deac082-B54","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1073\/pnas.97.4.1624","article-title":"Endogenous expression of Mullerian inhibiting substance in early postnatal rat sertoli cells requires multiple steroidogenic factor-1 and GATA-4-binding sites","volume":"97","author":"Watanabe","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022070318263463800_deac082-B55","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/molehr\/gah015","article-title":"Anti-mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment","volume":"10","author":"Weenen","year":"2004","journal-title":"Mol Hum Reprod"},{"key":"2022070318263463800_deac082-B56","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1093\/bioinformatics\/btq340","article-title":"METAL: fast and efficient meta-analysis of genomewide association scans","volume":"26","author":"Willer","year":"2010","journal-title":"Bioinformatics"},{"key":"2022070318263463800_deac082-B57","doi-asserted-by":"crossref","first-page":"D754","DOI":"10.1093\/nar\/gkx1098","article-title":"Ensembl 2018","volume":"46","author":"Zerbino","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2022070318263463800_deac082-B58","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3892\/etm.2016.3436","article-title":"Effects of testosterone on the expression levels of AMH, VEGF and HIF-1alpha in mouse granulosa cells","volume":"12","author":"Zhang","year":"2016","journal-title":"Exp Ther Med"},{"key":"2022070318263463800_deac082-B59","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1093\/bioinformatics\/btv328","article-title":"atSNP: transcription factor binding affinity testing for regulatory SNP detection","volume":"31","author":"Zuo","year":"2015","journal-title":"Bioinformatics"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/7\/1544\/44386172\/deac082.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/7\/1544\/44386172\/deac082.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T14:27:29Z","timestamp":1656858449000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/37\/7\/1544\/6572205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,22]]},"references-count":59,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,4,22]]},"published-print":{"date-parts":[[2022,6,30]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deac082","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7,1]]},"published":{"date-parts":[[2022,4,22]]}}}